September 8, 2025

Company to respond within stipulated timeframe; reiterates commitment to quality compliance Pharmaceutical major Lupin Ltd announced that the U.S. Food and Drug Administration (US FDA) recently completed a product-specific Pre-Approval Inspection (PAI) at its Chhatrapati Sambhajinagar (Aurangabad) manufacturing facility. The inspection, which took place between September 1 and…

September 5, 2025

Summary: Investor sentiment towards emerging markets (EMs) is showing signs of recovery, with capital flows expanding across multiple regions. According to EPFR Global, India-focused equity funds posted their first inflow in five weeks, while diversified EM funds also attracted fresh allocations—often seen as an early indicator of a…